Tamrisa

A specialized pharma venture to tackle anti-microbial resistance through innovation, stewardship and access. Tamrisa aims to provide a novel, comprehensive, ambitious and sustainable response to AMR threat, in line with WHO guidelines. The company is committed to developing new classes of antibiotics against top priority multi-drug resistant pathogens and reinforcing access for patients around the world to proven existing antibiotics.